Take charge of your studies with clear pricing and next-level tools
Provide speed and savings with a single platform that scales to support your client portfolio from beginning to end.
Business-winning
tools at your fingertips
- Leverage GenAI and automation to build higher quality studies faster and more efficiently, while de-risking data collection
- Generate study specific quotes in 30-seconds with our self-serve pricing calculator
- Walk into any kickoff or bid defense meeting with a pre-built digital study, ready for instant feedback and real-time updates
Flexible service tiers built for how you work
Managed Service
- End-to-end study builds by Medable
- Dedicated expertise from instrument and translation management to device provisioning
- Full enablement training, change management, and help desk support
Hybrid
- Unlimited sales/POC workspace for sponsor demos and meetings
- Collaborative Study Support
- Flexible Service Access
- Collaborative Training Approach
Self Service
- Fully enabled to manage builds independently
- Flexible add-on partner support from instrument and translation management to device provisioning
- Complete training, change management, and help desk support
- Priority roadmap input and early access for new AI capabilities and tech releases
Build smarter. Win bigger.
Create sponsor confidence with every milestone hit
Reach key milestones weeks ahead of schedule, from FPI to translations to build time, while boosting site and patient adherence rates.
Build and scale faster using Medable Studio with AI
Build 35x faster with unlimited workspaces, demo support for customer and bid defense meetings, and a portfolio content library that makes reuse and scale effortless.
Unlock more with our partner incentives
Get access to pricing tools, governance meetings, and sales workspaces-- everything you need to make faster, more informed decisions and scale efficiently.
Trusted By
The latest from Medable
.jpg)
Medable perspective: Three points on FDA eCOA guidance
At the beginning of April 2023, the FDA published a draft of the fourth in a series of Guidance Documents entitled “Patient-Focused Drug Development: Incorporating Clinical Outcome Assessments (COA) Into Endpoints For Regulatory Decision-Making”. Once finalized these four documents will be combined and will replace the 2009 Guidance, “Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims”. Part 3, which was released in draft in June 2022, provides advice around the development and validation of new COA (including the modification of existing COA).
Patient perspectives: Nine updated technology tips for deploying eConsent from Medable’s PCN
Since 2018, Medable has grown a network of patients, caregivers, and care partners whose job is to help improve the clinical trial experience for participants.
Known as the Patient Caregiver Network (PCN), they regularly update their best practices, including recently refreshing their technological best practices around deploying eConsent.
We’re sharing them below to help continually promote the participant's voice and to help foster more equitable, inclusive, and diverse clinical trials
Bridging the gap: Ensuring sites are successful with Medable
For years, clinical research sites have been vocal about the technological challenges they face conducting trials. Obstacles such as multiple disparate systems per trial, an abundance of passwords, lack of interoperability, and other issues all showcase how technology can be as significant a hindrance as it is a boon. As a recent Forbes article suggests, if clinical research technology doesn’t empower sites, it risks slowing down the entire trial.